Found 288 clinical trials
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
This study is designed to determine the efficacy and safety of colchicine in patients with chronic kidney disease.
- 0 views
- 29 Apr, 2022
- 1 location
Esmolol for Myocardial Protection in Hypertrophic Obstructive Cardiomyopathy
influence of esmolol in patients with hypertrophic obstructive cardiomyopathy undergoing cardiac surgery.
- 0 views
- 19 Oct, 2021
- 1 location
Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia
This is a Phase 1/2, open-label, dose-ascending, multicenter study of the safety and efficacy of LX2006 for participants who have Friedreich's Ataxia with evidence of cardiomyopathy. The first
- 0 views
- 07 Oct, 2022
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion (ADAPT)
Sepsis induces both a systolic and diastolic cardiac dysfunction. The prevalence of this septic cardiomyopathy ranges between 30 and 60% according to the timing of assessment and definition used
- 0 views
- 08 Apr, 2023
- 18 locations
AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment (ATACAR)Trial
Researchers are comparing two drug therapy plans to treat heart function changes after anthracycline-based treatment for lymphoma.
- 0 views
- 07 Oct, 2022
- 1 location
The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy
function and reduces abnormal heart rhythms in patients with hypertrophic cardiomyopathy (HCM). The study is also assessing how trientine works in HCM. Participants will be prescribed either trientine or
- 0 views
- 26 Mar, 2021
- 4 locations
Permanent Pacing for Drug-refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy. (PACE-OHCM)
Hypertrophic Cardiomyopathy (OHCM) to pacing, in terms of reduction of Left Ventricular Outflow Tract (LVOT) pressure gradient and functional capacity improvement. The Primary Objective is to
- 0 views
- 03 Apr, 2023
- 1 location
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
In this trial, the investigators will assess the effect of metoprolol in patients with hypertrophic cardiomyopathy who underwent alcohol septal ablation. The investigators will evaluate the
- 69 views
- 23 Mar, 2022
- 1 location
Bisoprolol for Early Cardiomyopathy in Duchenne Muscular Dystrophy: a Randomized, Controlled Trial
This study aimed to use cardiac magnetic resonance imaging (CMR) to evaluate the efficacy and safety of bisoprolol therapy for boys with Duchenne muscular dystrophy(DMD) and preserved ejection fraction. On top of angiotensin-converting enzyme inhibitor (ACEI) , half of the participants will receive bisoprolol in combination, while the other half …
- 0 views
- 14 Oct, 2022
Randomized Evaluation of Bromocriptine In Myocardial Recovery THerapy for Peripartum Cardiomyopathy (REBIRTH) (REBIRTH)
The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact
- 0 views
- 11 Oct, 2022
- 1 location